Protein structural and mechanistic basis of progeroid laminopathies. (3rd September 2020)

• Record Type: Journal Article
• Authors: Marcelot, Agathe; Worman, Howard J.; Zinn‐Justin, Sophie
• Is Part Of: FEBS journal. Volume 288:Number 9(2021)
• Page Start: 2757
• Page End: 2772
• Publication Date: 2020-09-03
• Subjects: 3D structure -- aging disorders -- contact sites -- lamin -- nuclear structure; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Pathology, Molecular -- Periodicals; 572
• DOI: 10.1111/febs.15526
• Languages: English
• ISSNs: 1742-464X

Abstract

Abstract : Progeroid laminopathies are characterized by the premature appearance of certain signs of physiological aging in a subset of tissues. They are caused by mutations in genes coding for A‐type lamins or lamin‐binding proteins. Here, we review how different mutations causing progeroid laminopathies alter protein structure or protein–protein interactions and how these impact on mechanisms that protect cell viability and function. One group of progeroid laminopathies, which includes Hutchinson‐Gilford progeria syndrome, is characterized by accumulation of unprocessed prelamin A or variants. These are caused by mutations in the A‐type lamin gene ( LMNA ), altering prelamin A itself, or in ZMPSTE24, encoding an endoprotease involved in its processing. The abnormally expressed farnesylated proteins impact on various cellular processes that may contribute to progeroid phenotypes. Other LMNA mutations lead to the production of nonfarnesylated A‐type lamin variants with amino acid substitutions in solvent‐exposed hot spots located mainly in coil 1B and the immunoglobulin fold domain. Dominant missense mutations might reinforce interactions between lamin domains, thus giving rise to excessively stabilized filament networks. Recessive missense mutations in A‐type lamins and barrier‐to‐autointegration factor (BAF) causing progeroid disorders are found at the interface between these interacting proteins. The amino acid changes decrease the binding affinity of A‐type lamins for BAF, which may contribute to lamina disorganization, as well as defective repair of mechanically induced nuclear envelope rupture. Targeting these molecular alterations in A‐type lamins and associated proteins identified through structural biology studies could facilitate the design of therapeutic strategies to treat patients with rare but severe progeroid laminopathies. Abstract : Progeroid laminopathies are characterized by the premature appearance of certain signs of physiological aging in a subset of tissues. They are caused by mutations in genes coding for A‐type lamins and associated proteins. These mutations cause either structural defects or altered protein interactions. Characterizing the molecular changes detected in patients through structural biology studies could facilitate the design of therapeutic strategies to treat these rare but severe diseases.